Search

everythinglearnresearchcommunity

for

Search:↓

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

A newborn with ichthyosis was successfully treated using specific neonatal care methods.

Expand access to prevention and address barriers for sex workers in Kostanay.

Dermatophytes, like Trichophyton rubrum, can cause allergies and chronic inflammation.

Pharmacy care clinics can reduce some emergency visits by managing certain conditions and medication issues.

Elderly skin care needs personalized treatment, early intervention, and integrated psychiatric care.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Poor sleep may lead to hair loss, and hair loss may affect sleep.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Early diagnosis and multidisciplinary care, including orthopedic surgery, can prevent long-term disability in IFAP syndrome.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

A combined treatment with microneedling and vitamin D3 led to complete hair regrowth in a woman with stubborn patch alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib is effective and safe for treating severe alopecia areata.

Targeting specific cell interactions may help treat skin fibrosis.

Alopecia areata involves specific gene changes and immune pathways, offering new treatment targets.

Body structure can help identify alopecia areata in Ukrainian men, but not predict its course.

Histopathological confirmation is crucial for accurately diagnosing challenging alopecia areata cases.

SH-SY5Y cell lysate is effective for diagnosing Satoyoshi syndrome.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

The visfatin GT genotype may increase the risk of Alopecia Areata.

These gene variations are not linked to alopecia areata in Egyptians.

Children with alopecia areata often experience more anxiety and depression, linked to neglectful family dynamics.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.